[go: up one dir, main page]

IT1398281B1 - COMPOSITION INCLUDING ALFA-LIPOIC ACID AND CARNOSINE FOR THE TREATMENT OF THE CPPS SYNDROME, OF THE CP AND / OR VULVODINIA SYNDROME - Google Patents

COMPOSITION INCLUDING ALFA-LIPOIC ACID AND CARNOSINE FOR THE TREATMENT OF THE CPPS SYNDROME, OF THE CP AND / OR VULVODINIA SYNDROME

Info

Publication number
IT1398281B1
IT1398281B1 ITMI2009A001375A ITMI20091375A IT1398281B1 IT 1398281 B1 IT1398281 B1 IT 1398281B1 IT MI2009A001375 A ITMI2009A001375 A IT MI2009A001375A IT MI20091375 A ITMI20091375 A IT MI20091375A IT 1398281 B1 IT1398281 B1 IT 1398281B1
Authority
IT
Italy
Prior art keywords
syndrome
vulvodinia
cpps
carnosine
treatment
Prior art date
Application number
ITMI2009A001375A
Other languages
Italian (it)
Inventor
Pier Luigi Guasti
Original Assignee
Difass S A Ora Farmapros S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Difass S A Ora Farmapros S P A filed Critical Difass S A Ora Farmapros S P A
Priority to ITMI2009A001375A priority Critical patent/IT1398281B1/en
Publication of ITMI20091375A1 publication Critical patent/ITMI20091375A1/en
Application granted granted Critical
Publication of IT1398281B1 publication Critical patent/IT1398281B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITMI2009A001375A 2009-07-30 2009-07-30 COMPOSITION INCLUDING ALFA-LIPOIC ACID AND CARNOSINE FOR THE TREATMENT OF THE CPPS SYNDROME, OF THE CP AND / OR VULVODINIA SYNDROME IT1398281B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI2009A001375A IT1398281B1 (en) 2009-07-30 2009-07-30 COMPOSITION INCLUDING ALFA-LIPOIC ACID AND CARNOSINE FOR THE TREATMENT OF THE CPPS SYNDROME, OF THE CP AND / OR VULVODINIA SYNDROME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A001375A IT1398281B1 (en) 2009-07-30 2009-07-30 COMPOSITION INCLUDING ALFA-LIPOIC ACID AND CARNOSINE FOR THE TREATMENT OF THE CPPS SYNDROME, OF THE CP AND / OR VULVODINIA SYNDROME

Publications (2)

Publication Number Publication Date
ITMI20091375A1 ITMI20091375A1 (en) 2011-01-31
IT1398281B1 true IT1398281B1 (en) 2013-02-22

Family

ID=41606678

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A001375A IT1398281B1 (en) 2009-07-30 2009-07-30 COMPOSITION INCLUDING ALFA-LIPOIC ACID AND CARNOSINE FOR THE TREATMENT OF THE CPPS SYNDROME, OF THE CP AND / OR VULVODINIA SYNDROME

Country Status (1)

Country Link
IT (1) IT1398281B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2789345A1 (en) * 2013-04-09 2014-10-15 Pizeta Group S.r.l. Composition for the treatment of endometriosis

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000027423A1 (en) * 2020-11-16 2022-05-16 Kolinpharma S P A MULTICOMPONENT COMPOSITION AND ITS USE IN THE TREATMENT OF PROSTATE DISEASES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0812590A3 (en) * 1989-11-09 1999-06-09 ASTA Medica Aktiengesellschaft Use of R-alpha lipoic acid for cytoprotection
US8178516B2 (en) * 1992-06-30 2012-05-15 Sylvan Labs, LLC Compositions and method for treatment of chronic inflammatory diseases
DE4327462A1 (en) * 1993-08-16 1995-02-23 Carl Heinrich Dr Weischer N-Acetyl-p-aminophenol derivatives for controlling pain
DE4331168A1 (en) * 1993-09-14 1995-03-16 Carl Heinrich Dr Weischer Combination of N-acetyl-p-aminophenol with sulphur-containing carboxylic acids such as alpha-lipoic acid and derivatives thereof for controlling states of pain
WO2003084532A1 (en) * 2002-04-03 2003-10-16 Avery Mitchell A Lipoic acid analogs useful as provitamins and antioxidants
RU2271203C1 (en) * 2004-05-27 2006-03-10 ГУ Новосибирский НИИ туберкулеза МЗ РФ (ННИИТ) Method for treating the syndrome of chronic pelvic pain caused by diseases of prostate and urinary bladder
DE102004035113A1 (en) * 2004-07-20 2006-02-16 Degussa Ag Composition for treating symptoms of cystic fibrosis comprises alpha-lipoic acid or a derivative thereof as the sole active ingredient
US20080031940A1 (en) * 2006-08-02 2008-02-07 Al Rodriguez Quercetin-containing composition, methods of making, and methods of using
JP2009078980A (en) * 2007-09-25 2009-04-16 Takahashi Gakuen Pain alleviating agent and pain alleviating assistance food

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2789345A1 (en) * 2013-04-09 2014-10-15 Pizeta Group S.r.l. Composition for the treatment of endometriosis

Also Published As

Publication number Publication date
ITMI20091375A1 (en) 2011-01-31

Similar Documents

Publication Publication Date Title
AP3179A (en) Benzofuranyl derivatives used as glucokinase inhibitors
LT2596786T (en) USE OF EIKOZAPENTAENIC ACID ETHYL ESTER FOR THE TREATMENT OF HYPERTRIGLYCIDEMIA
AP2012006085A0 (en) Inhibitors of flaviviridae viruses.
HUE045367T2 (en) Combination therapy for the treatment of diabetes
IL222534A0 (en) Predictive markers useful in the treatment of fragile x syndrome (fxs)
ZA201202613B (en) Spiro-condensed cyclohexane derivatives as hsl inhibitors useful for the treatment of diabetes
BRPI0917822A2 (en) v2o5 low porcelain enamels - v2o5 free
ZA201301799B (en) Process for the preparation of pan-cdk inhibitors of the formula (i),and intermediates of the preparation
IL199829A0 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
IL206904A0 (en) Beta--amino acid derivatives for treatment of diabetes
IL217966A0 (en) Hsl inhibitors useful in the treatment of diabetes
DK2241553T3 (en) Process for the preparation of ivabradine and its pharmaceutically acceptable acid addition salts
ZA201007911B (en) Processes for refolding of insulin
IT1397895B1 (en) PROCEDURE FOR SQUARE COMPENSATION
IT1396172B1 (en) INTEGRATED PROCEDURE FOR THE PRODUCTION OF HYDROGEN FROM SULFIDRIC ACID
SMT201600479B (en) NEW THERAPEUTIC SOLUTIONS FOR THE TREATMENT OF NEURO INFLAMMATORY CONDITIONS
IL211062A0 (en) Pharmaceutical uses of lanosta-8,24-dien-3-ols
IT1398281B1 (en) COMPOSITION INCLUDING ALFA-LIPOIC ACID AND CARNOSINE FOR THE TREATMENT OF THE CPPS SYNDROME, OF THE CP AND / OR VULVODINIA SYNDROME
IT1397023B1 (en) COMPOSITIONS INCLUDING AMINO ACIDS, FOR THE TREATMENT OF CHRONIC OSTRUCTIVE BRONCOPNEUMOPATHY
ZA201108702B (en) Piperidine derivatives useful for treatment of diabetes
PL2391366T3 (en) Substituted benzimidazoles for the treatment of astrocytomas
IT1399791B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NASAL POLYPOSIS
GB2460445B (en) Treatment of ringworm
IT1403250B1 (en) MACRO-PARTS FOR THE PRODUCTION AND TREATMENT OF GAS
FI20095850L (en) Structure and method for manufacturing the structure, and use of the structure